Biio

Revolutionizing Wearables to do a 100x and enabling Diabetes and Cardiovascular disease monitoring

Diabetes and CVDs are the most expensive, by dollars spent. In the US, 1 in 3 (133 M) Americans have diabetes or prediabetes. Only 2.4 M use continuous glucose monitoring as it costs on average $1800/year. CVDs affect 50% of Americans over the age of 45.

David (CTO)

David has over 20 years of experience. At Intel, he worked on 11 CPUs & GPUs. He was employee #4 at now Series C startup oneNav. where he co-delivered the first pureL5 GNSS.

Satyam (CEO)

Satyam led development of 7 devices including wearables within the medical/ aerospace industries.

What we do

Biio is enabling health computations unlike ever before!! With our Patent Pending Edge-AI solution, we are in a class of our own!

Unparalled Signal Quality

With its Biometric Engine, designed for Biometric applications, Biio achieves highest signal quality at the lowest power consumption.

100x Better Performance

Compared to a Normal CPU, Biio achieves over a 100x (closer to a 1000x) better performance per watt!

Additional Parameters

Current Solutions extract 1, Biio extracts over 15 additional parameters. Unlocking 10x more use cases!

>Privacy

Edge AI capabilities, so none of the most personal & sensitive data, i.e. health data ever leaves device and goes to cloud

Plug and Play

Plug and Play integrations within existing designs, shortening time to market and enabling additional usecases from day 1!

Edge-AI

Our Edge AI solution enables real time and continuous monitoring of the most chronic Diseases. All Cloudless!.

Get in touch

We are looking for partners with‌in wearables and research space, do reach out!